Florian Geismann

DFV890: a new oral NLRP3 inhibitor—tested in an early phase 2a randomised clinical trial in patients with COVID-19 pneumonia and impaired respiratory function

Ildikó Madurka, Alexander Vishnevsky, Joan B. Soriano et al. · Infection · 2022 · 83 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +10

ECMO in COVID-19—prolonged therapy needed? A retrospective analysis of outcome and prognostic factors

Esther Dreier, Maximilian Malfertheiner, Thomas Dienemann et al. · Perfusion · 2021 · 63 citations · Full text

Medicine, Respiratory Therapy, Pulmonary Function Testing +15

Comparative analysis of different transection techniques in minor and major hepatic resections: A prospective cohort study

Carina Riediger, Michael W. Mueller, Florian Geismann et al. · International Journal of Surgery · 2013 · 24 citations

Medicine, Surgery, General Surgery +8

Secondary hemophagocytic lymphohistiocytosis and severe liver injury induced by hepatic SARS-CoV-2 infection unmasking Wilson’s disease: Balancing immunosuppression

Matthias Lubnow, Bárbara Schmidt, Martin Fleck et al. · International Journal of Infectious Diseases · 2021 · 19 citations · Full text

Medicine, Infectious Diseases, Pathology +17

Does cerebral near‐infrared spectroscopy (NIRS) help to predict futile cannulation in extracorporeal cardiopulmonary resuscitation (ECPR)?

Clemens Wiest, Alois Philipp, Maik Foltan et al. · Resuscitation · 2021 · 13 citations · Full text

Health Professions, Neuroscience, Anesthesia +8